Sturctural Formula Of Letrozole (Image 1)
Letrozole Tablet, Film Coated
Product Images NDC 0093-7620
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 0093-7620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure01 (Image 2)
Figure02 (Image 3)
Figure03 (Image 4)
Not available.*
Figure04 (Image 5)
This text provides information regarding the time to progression (in days) for two treatment groups using different doses of Letrozole (0.5 mg and 2.5 mg).*
Figure05 (Image 6)
Image (Image 7)
This is a medication container label for Letrozole tablets. The tablets contain 2.5mg of Letrozole and are film-coated. The label provides dosage information and storage instructions. The medication should be kept in a tight, light-resistant container and out of reach of children. It also includes information about the manufacturer and distributor. The product contains FD&C Yellow No.5 as a color additive. The NDC (National Drug Code) is 0093-7620-56 and the GTIN (Global Trade Item Number) is 00300937620563. The label also includes a serialization coding area.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
